Related Experiment Video
Updated: May 6, 2026

Transtubular Endoscopic Posterolateral Decompression for L5-S1 Lumbar Lateral Disc Herniation
Published on: October 14, 2022
Lumbar disc herniation is an independent predictor of plaque burden in the patients with unstable angina
Yongchao Wang1, Junhua Ge1, Hao Xu1
1Department of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Insights
Lumbar disc herniation (LDH) is an independent risk factor for coronary atherosclerosis plaque burden. Evolocumab treatment significantly reduced cardiovascular events in patients with LDH and high plaque burden.
Area of Science:
- Cardiology
- Neurology
- Biochemistry
Background:
- Lumbar disc herniation (LDH) is a common condition.
- Coronary atherosclerosis is a leading cause of cardiovascular disease.
- The relationship between LDH and coronary plaque burden is not well understood.
Purpose of the Study:
- To assess the impact of lumbar disc herniation (LDH) on coronary atherosclerosis plaque burden.
- To investigate the association between LDH and cardiovascular risk factors.
- To evaluate the efficacy of evolocumab in treating LDH patients with high coronary plaque burden.
Main Methods:
- 212 patients with unstable angina undergoing coronary angiography were included.
- Patients were divided into LDH (n=106) and no LDH (n=106) groups.
- Gensini scores assessed plaque burden; logistic and Spearman analyses examined associations; Cox regression evaluated evolocumab treatment.
Main Results:
- LDH patients exhibited higher Gensini scores (P<0.01) and triglycerides (P=0.04), with lower HDL-C (P=0.01).
- LDH was an independent risk factor for higher Gensini scores (OR=2.38, P<0.01).
- Evolocumab significantly reduced MACE events (HR=0.26, P=0.04) in LDH patients with high plaque burden.
Conclusions:
- LDH is an independent risk factor for increased coronary plaque burden.
- LDH is associated with dyslipidemia, potentially contributing to plaque development.
- Evolocumab effectively reduces cardiovascular events in LDH patients with high coronary plaque burden.
Objective:
Assessing the impact of lumbar disc herniation (LDH) on the plaque burden of coronary atherosclerosis is our objective.
Methods:
In this study, a total of 212 patients (age 46-80 years) with unstable angina (UA) who underwent coronary angiography (CAG) in our hospital from January 2018 to July 2022 due to UA were included. Patients were divided into LDH group (n = 106) and no LDH group (n = 106). Gensini scores were calculated to assess the plaque burden of coronary. Logistic analysis was used to examine potential risk variables linked to the Gensini score. The association between lumbar disc lesions grading and coronary plaque burden was analysed by Spearman's correlation test. LDH patients with higher plaque burden (n = 56) were further divided into evolocumab treatment group (n = 28) and conventional treatment group (n = 28). Cox regression analysis were performed.
Results:
Patients with LDH had higher Gensini scores (P < 0.01) and triglyceride (TG) levels (P = 0.04), but HDL-C (P = 0.01) levels were lower. LDH was found to be an independent risk factor for higher Gensini scores (OR = 2.38, P < 0.01) by logistic analysis. The Spearman's correlation test suggested that the degree of lumbar disc lesions was related to the Gensini score and the level of blood lipid. Cox regression analysis showed that evolocumab treatment could significantly reduce the composite MACE events (cardiac death, nonfatal myocardial infarction, nonfatal stroke, and readmission due to angina) (HR = 0.26, P = 0.04) in higher coronary plaque burden patients.
Conclusion:
LDH is an independent risk factor for the higher coronary plaque burden. Evolocumab treatment significantly reduced the occurrence of cardiovascular events in LDH patients with higher plaque burden. Additionally, our data indicate that LDH is associated with increased blood lipid, which may contribute to the development of plaque burden.
Related Concept Videos
Angina II: Classification
Angina IV: Management
Peripheral Artery Disease I: Introduction
Herniated Intervertebral Disc l: Introduction
Degenerative Disc Disease I: Introduction
Degenerative Disc Disease ll: Pathophysiology

